Cholesterol Levels and Statin Use in Patients With Coronary Heart Disease Treated in Primary Care Settings
Introduction Therapy with 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, or statins, has proven to be effective in the treatment of lipid disorders. However, statin therapy continues to be underused, even though statins are a relatively safe and well-tolerated class of agents...
Main Authors: | Patrick J. O’Connor, MD, MPH, Richard J. Gray, MD, Michael V. Maciosek, PhD, Kelly M. Fillbrandt, BS, Terese A. DeFor, MS, Charles M. Alexander, MD, Thomas W. Weiss, DrPH, Steven M. Teutsch, MD, MPH |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2005-07-01
|
Series: | Preventing Chronic Disease |
Subjects: | |
Online Access: | http://www.cdc.gov/pcd/issues/2005/jul/04_0146.htm |
Similar Items
-
Paradoxical mortality differential of HDL cholesterol
by: Jyotishman Mukhopadhyay, et al.
Published: (2023-05-01) -
An Overview of the Impact of Statin Therapy on Cardiac Incident Risk
by: Urszula Świrk, et al.
Published: (2025-02-01) -
The treatment of cholesterol: issues, effects and targets
by: James A. Ker
Published: (2010-12-01) -
The comparative effectiveness of statin therapy in selected chronic diseases compared with the remaining population
by: Sheng Xia, et al.
Published: (2012-08-01) -
Statins significantly repress rotavirus replication through downregulation of cholesterol synthesis
by: Shihao Ding, et al.
Published: (2021-01-01)